Form 4 for MGNX MACROGENICS INC
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0000899243-23-005209 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-16 | 2023-02-14 | MGNX | BB BIOTECH AG | 10% | P - Purchase | $5.07 | +500.0K | 9.58M | +6% | +$2.54M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | P | A | 500,000 | $5.07 | 9,579,963 | D | — | — |